Corvus Pharmaceuticals Inc (NASDAQ:CRVS)
| 0.861 BATS BZX Real-Time Price As of 9:41am ET |  +0.0103 / +1.21%Today’s Change | 0.75 Today|||52-Week Range 9.54 | -64.27% Year-to-Date |
Latest CRVS News | Press Releases
No recent news for Corvus Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.85 |
| Today’s open | 0.86 |
| Day’s range | 0.86 - 0.86 |
| Volume | 1,200 |
| Average volume (3 months) | 296,015 |
| Market cap | $42.2M |
Data as of 9:41am ET, 08/11/2022
Growth & Valuation
| Earnings growth (last year) | -407.92% |
| Earnings growth (this year) | +18.45% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MTEXMannatech Inc | 0.00 | 0.00% |
| TRVNTrevena Inc | -0.00 | -0.38% |
| NYMXNymox Pharmaceutical... | 0.00 | 0.00% |
| ACSTAcasti Pharma Inc | 0.00 | 0.00% |
Data as of 9:34am ET, 08/11/2022
Financials
| Next reporting date | November 3, 2022 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$43.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Burlingame, California |
Forecasts
